Speaker's Highlight

  • Don Sin University of British Columbia, St. Paul Hospital (Canada)
    Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
  • Parameswaran Nair McMaster University (Canada)
    Carolyn Calfee UCSF (U.S.A.)
  • Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
    David A. Schwartz University of Colorado School of Medicine (U.S.A.)
  • Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
    Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
  • Nicola Hananiah Baylor College of Medicine (U.S.A.)
    Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
  • Koichiro Asano Tokai University School of Medicine (Japan)
    Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
  • Konstantinos Kostikas University of Ioannina (Greece)
    Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)
  • News

    Novel Anticoagulants for Pulmonary Embolism Care in AustraliaPulmonary embolism (PE) occurs when a blood clot, usually originating in a deep vein in the leg, travels to the pulmonary arteries. It can cause sudden…
    Managing Occupational Asthma in Today’s Australian WorkplaceOccupational asthma is asthma caused or aggravated by conditions at work. It may develop after repeated exposure to substances such as flour dust, isocyanates,…
    Periodontal Disease And COPD ExacerbationsChronic obstructive pulmonary disease (COPD) and periodontal disease frequently occur in the same patient, particularly where smoking, diabetes, ageing, poor…
    Precision Medicine In Idiopathic Pulmonary FibrosisIdiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease marked by scarring of the lung tissue and declining respiratory function. Its…
    Noninvasive Ventilation For Acute Respiratory Failure In The Emergency DepartmentAcute respiratory failure can deteriorate within minutes, yet invasive ventilation is not always the first or best option. Noninvasive ventilation (NIV),…
    CFTR Modulator Therapy For Adults In AustraliaCystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Adults has changed the management of cystic fibrosis (CF) from mainly treating…
    Climate Change and Respiratory Allergies in AustraliaClimate change is reshaping the conditions that trigger respiratory allergies. Warmer temperatures, shifting rainfall, longer pollen seasons and more frequent…
    Risk factors for COPD in people who have never smokedChronic obstructive pulmonary disease (COPD) is often associated with cigarettes, but tobacco exposure is not a requirement for developing the condition. A…
    Update on Diagnosis and Treatment of Allergic Bronchopulmonary AspergillosisAllergic bronchopulmonary aspergillosis (ABPA) is an immune-mediated reaction to Aspergillus fumigatus, usually affecting people with asthma or cystic…
    Biologics in severe asthma: a comparative reviewSevere asthma remains uncontrolled despite high-dose inhaled corticosteroids, a long-acting bronchodilator and careful attention to adherence, inhaler…
    Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
  • Mona Bafadhel King’s College London (United Kingdom)
    David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
  • James Chalmers University of Dundee (United Kingdom)
    David Price University of Aberdeen (United Kingdom)

Copyright ⓒ APSR2022 all rights reserved

APSR Congress Privacy Policy